FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A - 16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2003
ICON PLC
(Registrant's name)
0-29714
(Commission file number)
South County Business Park, Leopardstown, Dublin 18, Ireland.
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F.
Yes X No __
Indicate by check mark whether the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):
Yes __ No X
Indicate by check mark whether the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):
Yes __ No X
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes __ No X
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b):82 N/A
OTHER EVENTS.
The registrant hereby incorporates by reference the press release attached
hereto as Exhibit 99.1 into this report.
2
FINANCIAL STATEMENTS AND EXHIBITS.
(c) The following Exhibits are filed as part of this report:
EXHIBIT NO. DESCRIPTION
99.1 Press Release.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the,
undersigned thereunto duly authorized.
ICON PLC
January 31, 2003 /s/ Sean Leech
- --------------------------- -------------------------------
Date Sean Leech
Chief Financial Officer
4
Exhibit 99.1
ICON FILES REGISTRATION STATEMENT FOR AMERICAN DEPOSITARY SHARES
www.iconclinical.com
Dublin, Ireland, January 31, 2003 - ICON plc (NASDAQ: ICLR) announced that it
has filed a registration statement with the U.S. Securities and Exchange
Commission ("SEC") for a proposed offering of 3,000,000 American Depositary
Shares ("ADSs"), representing 3,000,000 ADSs. The offering is to be made in the
United States and Europe and includes 1,000,000 ADSs to be sold by Dr. Ronan
Lambe and 500,000 by Dr. John Climax, as selling shareholders, and a new
financing of 1,500,000 ADSs by ICON.
The offering will be underwritten by Goldman, Sachs & Co., William Blair &
Company, Bear, Stearns & Co. Inc. and Davy Stockbrokers. To the extent that the
underwriters sell more than 3,000,000 ADSs, the underwriters have been granted
an option to purchase up to 450,000 additional ADSs from the selling
shareholders.
A registration statement relating to the ordinary shares underlying the ADSs has
been filed with the SEC but has not yet become effective. These securities may
not be sold nor may offers to buy the securities be accepted prior to the time
that the registration statement becomes effective. This news release shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of the securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities law of any such jurisdiction.
Application will be made for the new ordinary shares to be listed on the Irish
Stock Exchange and listing particulars in relation to those shares will be
provided in due course ICON is a global clinical research organization, with 27
offices in 16 countries and has over 2,200 employees worldwide. A written
prospectus meeting the requirements of Section 10 of the Securities Act may be
obtained from Goldman Sachs & Co., Prospectus Department, 85 Broad Street, New
York, New York 10004 or (212) 902-1171, when available.
5